21-32514921-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_058187.5(EVA1C):c.1057G>A(p.Asp353Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,614,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_058187.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVA1C | NM_058187.5 | c.1057G>A | p.Asp353Asn | missense_variant | 8/8 | ENST00000300255.7 | NP_478067.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVA1C | ENST00000300255.7 | c.1057G>A | p.Asp353Asn | missense_variant | 8/8 | 1 | NM_058187.5 | ENSP00000300255 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 250996Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135662
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461848Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727224
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2022 | The c.1057G>A (p.D353N) alteration is located in exon 8 (coding exon 8) of the EVA1C gene. This alteration results from a G to A substitution at nucleotide position 1057, causing the aspartic acid (D) at amino acid position 353 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at